Iopamidol in the diagnosis of suspected upper gastro-intestinal perforation

Iodixanol in paediatric gastrointestinal imaging: safety and efficacy comparison with iohexol

Iodixanol (Visipaque) is a dimeric, non-ionic iodinated contrast medium that is isotonic with blood at all clinically relevant concentrations. Iodixanol was compared in a randomized, double blind, parallel group, phase III multicentre trial with a monomeric, non-ionic contrast medium, iohexol (Omnipaque), at two concentrations assessing safety, tolerability and radiographic efficacy during contrast enhanced gastrointestinal radiography examinations of children. 154 children entered the trial; 152 formed the safety population and 147 the efficacy population. All examinations were performed following standard departmental practice. Children were assigned into either a high or low concentration group (iodixanol, 150 mgI ml(-1) and 320 mgI ml(-1) vs iohexol, 140 mgI ml(-1) and 300 mgI ml(-1)). The primary outcome measure for efficacy was the overall quality of visualization, which was assessed using a 100 mm visual analogue scale (VAS). The secondary efficacy variables assessed were quality of contrast opacification, mucosal coating and overall quality of diagnostic information. Safety evaluation involved patient follow-up for at least 48 h. Taste acceptance was also assessed. There was no statistically significant difference between the two contrast media with regard to the primary and secondary efficacy variables assessed, although higher ratings were observed for iodixanol. The 100 mm VAS score overall was 86 mm for iodixanol and 82 mm for iohexol (95% confidence interval -2.56, 10.42). The frequency of adverse events was lower for patients receiving iodixanol. Adverse events, mainly diarrhoea, occurred in 12 patients (16.2%) in the iodixanol group and 28 patients (35.9%) in the iohexol group. This reached statistical significance (p=0.006). Overall, iodixanol is well suited for examinations of the gastrointestinal tract, giving good efficacy results and fewer adverse events than iohexol.

Efeitos do sulfato de bário na cavidade pleural de ratos

OBJETIVO: Avaliar os efeitos do sulfato de bário na cavidade pleural de ratos. MÉTODO: Foram avaliados, experimentalmente, os efeitos do sulfato de bário a 100% na cavidade pleural de 43 ratos. Sob anestesia inalatória com éter, foi realizada injeção de contraste radiológico (1ml) na cavidade pleural direita após punção com agulha romba pela via subxifóide. Os ratos, divididos em três grupos, foram mortos em câmara fechada com éter, após 24h (13 ratos), 48h (16 ratos) e 21 dias (14 ratos), respectivamente. Através de esternotomia longitudinal e laparotomia alta, foram retiradas a pleura parietal e visceral, juntas com o gradil costal e o pulmão direito. No grupo-controle, de 22 ratos, foi injetado 1ml de soro fisiológico a 0,9% na cavidade pleural direita. RESULTADOS: Não houve mortes entre os 43 ratos em que foi injetado sulfato de bário e no grupo-controle. As alterações encontradas na cavidade pleural dos grupos injetados com sulfato de bário e mortos com 24h e 48h foram semelhantes: leve e difusa hiperemia na pleura parietal, sulfato de bário livre, derrame pleural inflamatório com predomínio de polimorfonucleares; macrófagos na pleura fagocitando sulfato de bário e pleura com infiltrado predominantemente polimorfonuclear. Com 21 dias, o sulfato de bário estava localizado e bloqueado na região retroesternal e havia formação de sínfises pleurais intensas. No exame histopatológico das pleuras havia grande quantidade de macrófagos repletos de sulfato de bário, raros pigmentos de sulfato de bário no meio extracelular, importante proliferação fibroblástica em 13/14 (92%) casos e não ocorreu formação de granulomas. No grupo-controle (22 ratos), o exame histopatológico foi normal em todas as fases do experimento. CONCLUSÕES: a) o sulfato de bário causou derrame pleural inflamatório em todos os casos; b) com 21 dias ocorreu formação de sínfises pleurais em 100% dos casos; c) não houve formação de granuloma; d) em todas as fases do experimento não ocorreram óbitos.

Evaluation of "Gastromiro" for bowel opacification during computed tomography: comparison with diatrizoate and barium sulphate

A new oral formulation of iopamidol, "Gastromiro", was evaluated as a bowel contrast agent during abdominal computed tomography (CT). Comparison was made with the well established agents sodium/meglumine diatrizoate ("Urografin 370") and dilute barium sulphate ("E-Z CAT") in a randomized, blind study of 150 consecutive patients undergoing abdominal and/or pelvic CT. Parameters assessed included quality of bowel opacification, artefact generation, contrast-medium palatibility, side effects and cost. No significant difference was found between the three contrast media in stomach- or small-bowel opacification. E-Z CAT was superior at opacifying the caecum/ascending colon. No compelling reason to choose a particular agent was found in the other assessed parameters, but cost is a significant factor.

Bacterial contamination of contrast media stored after opening

A barium suspension, iohexol, iopamidol and ioxaglate which were diluted with tapwater and 0.9% NaCl and dextrose saline (4% and 0.18%) were made into aliquots of 10 ml and stored at 4 degrees C, room temperature and 37 degrees C for 8 weeks. Regular handling and bacterial cultures were performed. These studies confirmed that environmental organisms do contaminate these solutions and that they also support viable organisms, but do not become significantly colonized at room temperature or 4 degrees C. The solutions should be stored at room temperature or at 4 degrees C. The diluted barium solution was the contrast medium least contaminated and if it is not contra-indicated for other reasons should be used in preference to low osmolality water soluble contrast media on the basis of its cost, radiological contrast and low microbial contamination rate.

Aspiration of high-density barium contrast medium causing acute pulmonary inflammation--report of two fatal cases in elderly women with disordered swallowing

Two cases are reported in which accidental inhalation of barium contrast medium occurred owing to disordered swallowing in elderly women. In each case there was a pulmonary inflammatory reaction followed within a few hours by death. Experimental and clinical reports of barium inhalation are reviewed and the hazard of aspiration of high density barium preparations in elderly and debilitated patients with dysphagia is emphasised. It is concluded that particular care should be taken in the radiological examination of such patients, and a suggested method for performing a contrast swallow in those who are liable to aspirate is described.

Oesophageal tears during pneumatic balloon dilatation for the treatment of achalasia

Fifty-eight contrast studies of the oesophagus, performed in patients shortly after balloon dilatation for the treatment of achalasia, were reviewed for evidence of perforation. Forty-nine examinations (85%) were normal and nine studies (15%) were abnormal. Three main radiological patterns were observed. Complete rupture of the oesophagus occurred in two cases. Incomplete tears of the oesophageal wall were present in seven cases: in one patient there was a linear mucosal tear while in six patients there was a localised outpouch or diverticulum. All patients with abnormal contrast studies were successfully managed conservatively. The range of radiological appearances of the distal oesophagus following balloon dilatation should be recognised to avoid unnecessary surgical intervention.